Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice companies, today announced that William F. Borne, Chief Executive Officer, and Ronald A. LaBorde, President and Chief Financial Officer, will present at the Raymond James 33rd Annual Institutional Investors Conference in Orlando, FL on Wednesday, March 7, 2012.

The presentation will begin at 8:40 a.m. Eastern. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.

About Amedisys:

Amedisys, Inc. (NASDAQ: AMED) is a leading health care company focused on bringing home the continuum of care. Amedisys delivers personalized health care services to patients and their families in the comfort of patients' homes. Amedisys care teams delivered 11 million patient care visits in 2011. Amedisys has two divisions, home health care and hospice. The Company's state-of-the-art advanced chronic care management programs and leading-edge technology enables it to deliver quality care based upon the latest evidence-based best practices. Amedisys is a recognized innovator, being one of the first in the industry to equip its clinicians with point-of-care laptop technology and referring physicians with an internet portal that enables real-time coordination of patient care seamlessly. Amedisys also has the industry's first-ever nationwide Care Transitions program. Amedisys Care Transitions is designed to reduce unnecessary hospital readmissions through patient and caregiver health coaching and care coordination, which starts in the hospital and continues throughout completion of the patient's home health plan of care. For more information about the Company, please visit: http://www.amedisys.com.

Our company website address is http://www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").

Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Amedisys Charts.
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Amedisys Charts.